Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
In your 30s? It's time to boost your income! Discover practical strategies to increase your earnings and achieve your goals.
19,736 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Sidus Space (SIDU) 2025 presents a micro-cap story in the space economy. This article breaks down the business, what ...
When markets wobble, the strength of a company’s balance sheet and its cash runway often beat a glossy business story...
On a day when markets shuddered, TJX stood out as its shares rose. A mix of solid earnings signals, a supportive anal...
A Monday rally in Bitcoin often sparks questions: what sparked the move, and is it the start of a longer trend? This ...
What could push the aave token could climb in the next decade? This guide breaks down the catalysts, risks, and pract...
A sweeping elder fraud operation hinged on convincing seniors to mail cash. This in-depth guide breaks down how the s...
A group of traders claims Polymarket retroactively altered a settlement rule, turning a winning 'Yes' bet on a Bitcoi...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
The beaten-down Figma shares rebound has investors weighing future growth, margins, and valuation. This guide breaks ...
NVIDIA just delivered spectacular quarterly results that surpassed expectations and reinforced its leadership in AI c...
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...